Enter your login e-mail to the account
Search
- Management of treatment-related adverse effects in renal cell carcinoma
MUDr. Martin Matějů, Ph.D., MUDr. Michal Zubaľ
(1/2024, From the frontier of urology )
- Úvodné slovo
MUDr. Tomáš Šálek
(3/2013, Editorial ) - Systemic treatment of malignant melanoma
MUDr. Iveta Andrezálová Vochyanová
(3/2013, Main topic ) - Biologic and targeted therapy for urogenital maliginities
MUDr. Mária Rečková
(1/2011, Review articles ) - Castration resistant prostate cancer in the year 2013
doc. MUDr. Jozef Marenčák, PhD.
(3/2013, Review articles ) - Review of of pharmacotherapy of metastatic melanoma
MUDr. Slavomír Urbanček, PhD.
(6/2016, Main topic ) - Gastrointestinal toxicity, hepatotoxicity and nephrotoxicity of targeted treatment
MUDr. Branislav Bystrický, MUDr. Alexandra Szabová
(1/2013, Main topic ) - News in the immunotherapy of nonmetastatic non-small-cell lung cancer
MUDr. Lenka Medvecová
(1/2023, Main topic ) - Immune checkpoint inhibitors in non-small cell lung cancer therapy
MUDr. Mária Černá, CSc.
(6/2015, Main topic ) - New trends in the immunotherapy of cancer
MUDr. Ján Lakota, CSc.
(6/2016, Review articles ) - Immune Checkpoint Blockade in Cancer Therapy
doc. MUDr. Peter Beržinec, CSc.
(3/2015, Information & comments ) - Správa z Best of ASCO® Slovakia 2015
MUDr. Mária Rečková
(6/2015, Events ) - Mucosal melanoma of the head and neck
MUDr. Michal Rosoľanka, prof. MUDr. Milan Profant, CSc., MUDr. Alica Lužáková, MUDr. Peter Hlavčák, PhD.
(2/2012, Review articles ) - Ipilimumab in the treatment of malignant melanoma
MUDr. Róbert Godál
(3/2011, Drugs & drug classes ) - Phase III Trial of Ipilimumab Combined With Paclitaxel and Carboplatin in Advanced Squamous Non–Small-Cell Lung Cancer
Doc. MUDr. Peter Beržinec, CSc.
(5/2017, Information & comments ) - Immunotherapy in prostate cancer
MUDr. Katarína Rejleková, PhD.
(5/2020, Review articles ) - Can we expect „ A new era“ in melanoma?
MUDr. Zuzana Hlavatá
(5/2011, Review articles ) - Rectal malignant melanoma mistaken for thrombotic hemorrhoids – rare tumor with poor prognosis
MUDr. Vladimír Šišovský, PhD., MUDr. Michal Palkovič, PhD., doc. MUDr. Soňa Kiňová, PhD., MUDr. Eva Kováčová, PhD., MUDr. Andrea Hvizdáková, PhD.³, MUDr. Milan Vyskočil, PhD., MUDr. Daniela Kobzová
(4/2011, Original articles & case reports ) - The use of immunotherapy in pediatric oncology
MUDr. Viera Bajčiová, CSc.
(1/2014, Review articles ) - Castration resistant prostate cancer – something new in the year 2014?
doc. MUDr. Jozef Marenčák, PhD.
(4/2014, Main topic ) - Správy z podujatia ASCO Chicago 2014
prof. MUDr. Stanislav Špánik, CSc., MUDr. Mária Rečková, MUDr. Patrik Palacka, PhD. MPH, MBA
(4/2014, Events ) - Mechanizmy imunitného systému v boji proti nádorom a príčiny ich zlyhania
Doc. MUDr. Mária Bucová, CSc., MUDr. Kristína Klučková, Prof. MUDr. Milan Buc, DrSc.
(2/2018, Main topic ) - Pokrok v imunoterapii malígneho melanómu a karcinómu pľúc inhibítormi imunitných kontrolných bodov
MUDr. Róbert Godál
(2/2018, Main topic ) - Nežiaduce účinky imunoterapie a ich manažment
MUDr. Jaroslava Lešková
(2/2018, Main topic ) - Zriedkavý nádor hrudníka: malígny pleurálny mezotelióm
MUDr. Lucia Denková, MUDr. František Sándor, PhD., FCCP
(3/2018, Main topic ) - Zriedkavé nádory gastrointestinálneho systému s akcentom na análny karcinóm
MUDr. Tomáš Šálek
(3/2018, Main topic ) - Adjuvant treatment of stage III melanoma after complete resection
MUDr. Silvia Jurišová, PhD.
(2/2022, Review articles ) - Správy z podujatia ASCO Chicago 2015
(4/2015, Events ) - Biological therapy in colorectal cancer
MUDr. Jozef Dolinský
(2/2011, Review articles ) - Immunotherapy for lung cancer
doc. MUDr. Peter Beržinec, CSc.
(4/2016, Main topic ) - Current possibilities of immunotherapy in the treatment of malignant melanoma
MUDr. Iveta Andrezálová Vochyanová
(4/2016, Main topic ) - Immune therapy of metastatic renal cell carcinoma
MUDr. Michal Chovanec, PhD.
(4/2016, Main topic ) - Ipilimumab – new drug, new experience
MUDr. Zuzana Hlavatá, PhD.
(5/2013, Original articles & case reports ) - Správa z Best of ASCO® Slovakia 2011
MUDr. Mária Rečková
(1/2012, Events ) - Malignant melanoma in children and adolescents
MUDr. Viera Bajčiová, CSc.
(1/2016, Main topic ) - Články publikované v časopise Onkológia v roku 2011 – prehľad
(1/2012, online attachment ) - Antitumor immunity
MUDr. Ján Lakota, CSc., MUDr. Milan Žuffa, CSc.
(2/2015, Review articles ) - Initial treatment of metastatic renal cell carcinoma
MUDr. Jana Obertová, PhD.
(1/2018, Main topic ) - Nivolumab in the renal cell carcinoma treatment
MUDr. Bc. Patrik Palacka, PhD., MPH, MBA, LL.M., Vladimíra Baranová
(1/2018, Main topic ) - Chemotherapy and imunotherapy for malignant melanoma
MUDr. Slavomír Urbanček, PhD.
(3/2009, Review articles ) - Systemic treatment of metastatic renal cell carcinoma after failure of the first line of treatment
MUDr. Dagmar Sudeková
(1/2018, Main topic ) - Treatment metastatic gastric cancer
MUDr. Vanda Ušáková, PhD.
(1/2018, Review articles ) - Pancreatic and biliary cancer
MUDr. Filip Kohútek, PhD., MUDr. Tomáš Sedláček, MUDr. Branislav Bystrický, PhD., MPH
(1/2018, Review articles ) - Niektoré nové poznatky zo sympózia ASCO GI San Francisco 2018
MUDr. Tomáš Šálek
(1/2018, Events )
- Cutaneous adverse effects of targeted oncologic therapies
MUDr. Katarína Poláková, PhD.
(1/2016, Topic of the year ) - Encorafenib a binimetinib v liečbe pokročilého malígneho melanómu
MUDr. Tomáš Šálek
(3/2018, Information & comments ) - Novinky v dermatoonkológii
(1/2018, Information & comments ) - Review of of pharmacotherapy of metastatic melanoma
MUDr. Slavomír Urbanček, PhD.
(4/2016, Topic of the year ) - Brief overview of surgical and pharmacological treatment of melanoma
MUDr. Slavomír Urbanček, PhD.
(2/2011, Review articles ) - Správy z podujatia ASCO Chicago 2015
(2/2015, Events )
- Biological drugs from the perspective of pharmacy
PharmDr. Katarína Bruchatá, PhD., Mgr. Peter Heinz
(4/2014, Pharmaceutical technology ) - Nové liečivá v EÚ registrované v roku 2011 (II.)
PharmDr. Peter Stanko
(2/2012, New drugs )